BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Total 2018 revenue increased 71 percent to $454 million, and 934,000 people were screened with Cologuard

  Nearly 15,000 healthcare providers ordered their first Cologuard test during the fourth quarter, and approximately 147,000 have ordered since the test was launched

  February 21, 2019

   · 

  9 min read
• Biotech Beach

  HCP to Present at Citi’s 2019 Global Property CEO Conference

  HCP, Inc. announced that Tom Herzog, its President and CEO, is scheduled to present at Citi’s 2019 Global Property CEO Conference in Hollywood, Florida.

  February 21, 2019

   · 

  1 min read
• Business

  eHealth, Inc. Announces Fourth Quarter and Fiscal 2018 Results

  Revenue for the fourth quarter of 2018 was $134.9 million, an increase of 62% compared to $83.1 million for the fourth quarter of 2017.

  February 21, 2019

   · 

  56 min read
• Deals

  Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2018 on Thursday, February 28, 2019, After Close of U.S.-Based Financial Markets

  Nektar Therapeutics will announce its financial results for the fourth quarter and year-ended December 31, 2018, on Thursday, February 28, 2019, after the close of U.S.-based financial markets.

  February 21, 2019

   · 

  1 min read
• Business

  Universal Display Corporation Announces Fourth Quarter and Full Year 2018 Financial Results

  Universal Display Corporation, enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, reported financial results for the fourth quarter and full year ended December 31, 2018.

  February 21, 2019

   · 

  14 min read
• Deals

  Halo Labs Commences Trading on the OTCQB Venture Market in the United States under the Symbol AGEEF

  Halo Labs Inc. is pleased to announce that OTC Markets Group Inc. has approved the trading of Halo Labs’ shares on the OTCQB Venture Market.

  February 21, 2019

   · 

  6 min read
• Policy

  PharmaEssentia and AOP Orphan Receive EU Approval of Besremi™ (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU

  PharmaEssentia announced that the European Commission has approved Besremi® as monotherapy in adults for the treatment of polycythaemia vera without symptomatic splenomegaly.

  February 21, 2019

   · 

  3 min read
• Drug Development

  Enzychem Lifesciences Completes Stage 1 Patient Enrollment in Phase 2 CRIOM Study

  Enzychem Lifesciences, Corp. announced that the company has achieved a huge milestone by completing enrollment of the required 24 patients in Stage 1 of the Phase 2 CRIOM study.

  February 21, 2019

   · 

  2 min read
• Biotech Bay

  iSchemaView’s RAPID™ Approved for Use in Brazil

  iSchemaView Expands RAPID’s South American Footprint by Bringing Brazil the Only Clinically Validated, Next-Generation Imaging Platform for Assessing Ischemic Stroke

  February 21, 2019

   · 

  4 min read
• Business

  ADDING MULTIMEDIA Dicerna Bolsters Leadership Team to Support Continued Growth

  — Regina DeTore Paglia Joins Company as Senior Vice President of Human Resources — Rebecca Peterson Hired as Head of Corporate Communications — Hardean E. Achneck, M.D., Joins as Vice President, Head of Medical Development

  February 21, 2019

   · 

  7 min read